Benitec Biopharma (BNTC) Q2 2026 Earnings

May 14Confirmed
Q3 2025
Q4 2025
Q1 2026
Q2 2026
-0.45
-0.37
-0.3
-0.22

Details

Expected EPS
-0.268333
Actual EPS
-0.24
Surprise EPS
0.03
Surprise Percent
+10.56%

Description

⁨Benitec Biopharma⁩ (⁦BNTC⁩) has reported earnings of ⁦-0.24⁩ per share for ⁦Q2 2026⁩.

0 Comments

Share your thoughts